Celgene Shares Respond To Word Of Markman Opinion Release
May 27, 2014 at 14:23 PM EDT
Shares of Celgene (NASDAQ: CELG) are volatile following the report of the Markman opinion on a patent dispute over five claims ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.